Skip to main content
. 2003 Nov;163(5):1929–1936. doi: 10.1016/S0002-9440(10)63551-1

Table 1.

Clinical and Molecular Data

Patient, sex Family history Age at onset (years) Age at biopsy (years) CK at biopsy (U/L) Muscle pathology severity Clinical grade at biopsy Clinical grade at last exam Nucleotide change Amino acid change Exon Zygosity Mutation type
1, M 17 29 1603 Active Severe Severe (46) G1469A R490Q 11 Homoz. Missense
2, F + 28 30 783 Active Moderate Severe (36) G1469A R490Q 11 Homoz. Missense
3, M* + 37 43 4348 Mild Mild Mild (49) G1469A R490Q 11 Homoz. Missense
4, M* + 10 10 5960 Mild Asymptom Moderate (26) G1469A R490Q 11 Homoz. Missense
5, M 11 16 3200 Mild Asymptom. G1469A R490Q 11 Heteroz. Missense
G1466A R489Q 11 Heteroz. Missense
6, M 20 20 5200 Moderate Mild Mild (26) 550 del. A 4 Heteroz. Frame-shift
G1469A R490Q 11 Heteroz. Missense
7, M 11 18 2500 Moderate Moderate Moderate/severe (25) 550 del. A 4 Heteroz. Frame-shift
C1468T R490W 11 Heteroz. Missense
8, M 16 21 8600 Moderate Mild Moderate (30) C1468T# R490W 11 Heteroz. Missense

*, second-degree cousins;

Age of patient at last clinical follow-up is indicated in parentheses,

#, only one mutant allele was found.

asymptom., asymptomatic, homoz., homozygous; heteroz., heterozygous